HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells
HR+HER2- 具有生长因子受体介导的 EMT 的乳腺癌预后较差,而拉帕替尼可下调 MCF-7 细胞中的 EMT
期刊:Tumor Biology
影响因子:
doi:10.1177/1010428317695028
Krisha Desai, Radhika Aiyappa, Jyothi S Prabhu, Madhumathy G Nair, Patrick Varun Lawrence, Aruna Korlimarla, Anupama Ce, Annie Alexander, Rohini S Kaluve, Suraj Manjunath, Marjorrie Correa, B S Srinath, Shekhar Patil, Anjali Kalamdani, Msn Prasad, T S Sridhar